Aspera Biomedicines
PrivateLast Round
Series A
May 18, 2026
Total Funding Raised
$3.2M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Aspera Biomedicines operates in Healthcare & Life Sciences and is based in La Jolla, California. Its latest recorded funding round was a Grant round in May 2025.
Aspera Biomedicines is a biotechnology company that develops space-accelerated cancer stem cell therapies targeting the ADAR1 protein to prevent cancer relapse.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Space Technology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aspera Biomedicines Comparables
Compare Aspera Biomedicines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Covant Therapeutics | 78% | |
| STORM Therapeutics | 77% | |
| Accent Therapeutics | 77% |
For institutional investors. Book with your work email.
Aspera Biomedicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 18, 2026 | ||||
| Grant | May 29, 2025 |
For institutional investors. Book with your work email.
Aspera Biomedicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| California Institute for Regenerative Medicine | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 18, 2026
$35M round completed.
For institutional investors. Book with your work email.
Aspera Biomedicines Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Aspera Biomedicines's valuation, stock price, and market status.
Is Aspera Biomedicines a public or private company?
Aspera Biomedicines is a private company.
What is the current stock price of Aspera Biomedicines?
Aspera Biomedicines is a private company, so its shares have no public market price. Caplight tracks Aspera Biomedicines's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aspera Biomedicines worth (valuation)?
Valuation information for Aspera Biomedicines is not publicly available.
Can I buy Aspera Biomedicines stock?
Aspera Biomedicines shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aspera Biomedicines's last funding round?
Aspera Biomedicines's most recent funding round was Series A on May 18, 2026.
Who are the main investors in Aspera Biomedicines?
Key investors in Aspera Biomedicines include California Institute for Regenerative Medicine.
Will Aspera Biomedicines IPO soon?
No public IPO plans have been announced for Aspera Biomedicines.
How can I track Aspera Biomedicines secondary market activity?
Caplight tracks bids, offers, and trades in Aspera Biomedicines's shares on secondary markets.